Titlebook: Cardiac Valve Replacement; Current Status Jack M. Matloff Book 1985 Springer Science+Business Media Dordrecht 1985 atherosclerosis.embolism

異端邪說2

描繪

Transfusion

平息

Book 1985neric cardiac valvular surgery meeting, focusing primarily on valve replacement rather than valve repair [2]. Thus, these proceed- ings contain a wide spectrum of topics, including a keynote presentation on criteria for selection of cardiac valve substitutes in 1984, complications of cardiac valve r

oxidize

a more generic cardiac valvular surgery meeting, focusing primarily on valve replacement rather than valve repair [2]. Thus, these proceed- ings contain a wide spectrum of topics, including a keynote presentation on criteria for selection of cardiac valve substitutes in 1984, complications of cardiac valve r978-1-4612-9629-4978-1-4613-2601-4

CRUMB

expound

st three symposia on this topic were held primarily for designated investigators involved in clinical trials of the ST. JUDE MEDICAL valve. The last meeting, chaired by Michael E. DeBakey, M.D., was held in November 1982 [1], immediately before the valve was released for general clinical use in the

GREEN

harbinger

Vittorio Degiorgio,Ilaria Cristianitely, bioprosthesis must still be considered a temporary valve substitute. Due to its limited durability, one must consider the risks of future reoperation for valve replacement when weighing the potential benefits of a bioprosthesis. This chapter assesses the risks of valve reoperation and its effect on subsequent longevity.

Nausea